AXIM
AXIM Biotechnologies, Inc.
Set alert
- YTD
- -72.73%
- 1 year
- -62.50%
- Open
- 0.003
- Prev close
- 0.003
- Mkt cap
- 1.05M
- Vol
- 32.18K
- Avg vol
- 340.23K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.003
- High
- 0.0033
News
2 years ago globenewswire.com
VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM's Diagnostic Research Programs in Dry Eye Disease and Parkinson's
2 years ago globenewswire.com
AXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation
The Company's Commercialization Partner Verséa Ophthalmic Places Re-stock Order of AXIM's Digital Assay Reader SAN DIEGO, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – AXIM…
2 years ago globenewswire.com
AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production
Leading Diagnostic Healthcare Company Signs Contract Manufacturing Agreement in Order to Fulfill Sales of IgE and Lactoferrin DED Diagnostic Assays
3 years ago businesswire.com
AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test
SAN DIEGO--(BUSINESS WIRE)--AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today…
3 years ago globenewswire.com
Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform
3 years ago globenewswire.com
AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform
5 years ago globenewswire.com
AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological,…
5 years ago globenewswire.com
AXIM® Biotechnologies Appoints Leading US Ophthalmic Surgeon and Researcher Dr. Henry D. Perry to its Medical Advisory Board
Dr. Perry is Third World-Class Ophthalmologist to Join the Advisory Board Dr. Perry is Third World-Class Ophthalmologist to Join the Advisory Board
5 years ago globenewswire.com
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board
Dr. Periman Joins Chairman Joseph Tauber as Advisory Board's Second Member Dr. Periman Joins Chairman Joseph Tauber as Advisory Board's Second Member
5 years ago globenewswire.com
AXIM® Biotech Appoints Ophthalmic Industry Veteran Jeff Busby as Senior VP Business Development
Busby to Direct Dry Eye Disease Commercial Launch for Recently Acquired Diagnostic Tech Busby to Direct Dry Eye Disease Commercial Launch for Recently Acquired Diagnostic Tech
5 years ago globenewswire.com
AXIM® Biotechnologies' Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological,…
5 years ago globenewswire.com
AXIM® Biotechnologies' Manufacturing Partner Empowered Diagnostics Files for Approval for Use of Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations in Canada and the EU
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological…
5 years ago globenewswire.com
AXIM® Biotechnologies Successfully Completes Point-of-Care Clinical Trials on its Rapid COVID-19 Neutralizing Antibody Test
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological…
-
6 years ago benzinga.com
Cannabis Stock Gainers And Losers From September 1, 2020
Gainers: Body & Mind Inc (OTC: BMMJ) shares closed up 17.73% at $0.29 Auxly Cannabis Group Inc (TSE: XLY) shares closed up 12.50% at $0.18 MedMen Enterprises Inc (CSE: MMEN) shares closed up 11.54%…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Wednesday
-
9 years ago benzinga.com
Garbage Companies & The Marijuana Industry: Expert Warns About Overvalued Cannabis Stocks
Garbage Companies & The Marijuana Industry: Expert Warns About Overvalued Cannabis Stocks
-
9 years ago benzinga.com
Marijuana Roundup: Jeff Sessions Remains A Wild Card, 68% Of Cops Support Legalization
Marijuana Roundup: Jeff Sessions Remains A Wild Card, 68% Of Cops Support Legalization
-
9 years ago benzinga.com
5 Overvalued Cannabis Stocks - Part 3: People Price Cannabis Stocks Like Lottery Tickets
5 Overvalued Cannabis Stocks - Part 3: People Price Cannabis Stocks Like Lottery Tickets